Association Between Circulating Regulator of Calcineurin 2 Concentrations With Overweight and Obesity

Author:

Wang Hongya,Fang Xia,Ren Qian,Zeng Yan,Tan Xiaozhen,Ye Ting,Fan Jiahao,Xu Yong

Abstract

BackgroundRegulator of calcineurin 2 (RCAN2) has been reported to promote food intake and weight gain in animal studies. However, its effect on body weight in humans is unclear.ObjectiveThis study aimed to investigate the relationship between serum RCAN2 concentrations and participants with overweight/obesity.MethodsA cross-sectional study was performed in 872 Chinese adults, including 348 participants with normal weight (NW), 397 participants with overweight (OW), and 127 participants with obesity (OB). All participants were divided into NW, OW and OB groups according to their body mass index (BMI). Serum RCAN2 concentrations were determined by enzyme-linked immunosorbent assay.ResultsSerum RCAN2 concentrations gradually increased with the increase of BMI (p < 0.001). The percentages of OW/OB gradually increased in tandem with increasing tertiles of RCAN2 (p < 0.001). Additionally, serum RCAN2 concentrations were significantly correlated with a series of anthropometric and metabolic parameters, predominantly including body weight, BMI, SBP, DBP, total cholesterol, triglycerides, HDL-C, LDL-C (all p < 0.05). Furthermore, logistic regression analysis showed that the risk of OW/OB was significantly increased with the increase of serum RCAN2 concentrations. Receiver operation characteristic (ROC) curve analysis revealed that serum RCAN2, especially serum RCAN2/(AST/ALT) ratio, might serve as a candidate biomarker for obesity.ConclusionSerum RCAN2 concentrations were increased in subjects with OW/OB. The increased serum RCAN2 concentrations were associated with the increased risks of OW/OB.

Publisher

Frontiers Media SA

Subject

Endocrinology, Diabetes and Metabolism

Reference35 articles.

1. Obesity and Overweight

2. Diagnosis of Obesity and Use of Obesity Biomarkers in Science and Clinical Medicine;Nimptsch;Metabolism,2019

3. Obesity: Global Epidemiology and Pathogenesis;Bluher;Nat Rev Endocrinol,2019

4. Metabolically Healthy Obesity;Bluher;Endocr Rev,2020

5. Global Health Observatory (Gho) Data

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3